Specialties

Neurosurgery (Board certified since 1989)

At a Glance

  • 1987 Started practicing
  • 30 Years experience
  • 2 OFFICE LOCATIONS
  • 3 HOSPITAL AFFILIATIONS

About Dr. Olson

My Clinical Interests

  • acoustic neuroma
  • brain surgery
  • brain tumors
  • central nervous system tumors
  • chiari malformations
  • cranial nerve disorder
  • hemangioma
  • hydrocephalus
  • muscle and nerve biopsy
  • osteomyelitis
  • skull base tumors
  • spinal cord tumors
  • stereotactic surgery

Academic Profile

Training

MEDICAL SCHOOL

University of Minnesota Hospital, Minneapolis, MN

INTERNSHIP

University of Iowa Hospitals, Iowa City, IA

RESIDENCY

University of Iowa College of Medicine, Iowa City, IA

FELLOWSHIP

National Institute of Health, Bethesda, MD

Professional Memberships

American Association of Neurological Surgeons

American College of Surgeons

Cancer Committee, Emory University Hospital

Congress of Neurological Surgeons

Eastern Cooperative Oncology Group

Georgia Neurosurgical Society

Neuro-Oncology Working Group, WCI

PET Center Committee

Radiation Therapy Oncology Group

Research Society of Neurosurgery

Society of Surgical Oncology

Stroke Council of the American Heart Association

Honors & Awards

Young Investigator Award - AANS

Major Publications

A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting. Molecular Therapeutics,10(5):958-66.

Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors. Clinical Cancer Research,10(24): 8603-8612.

Correlation of the response of recurrent malignant gliomas treated with interferon with tumor interferon  gene content. International Journal of Oncology,25: 419-427.

Identification of a novel small molecule inhibitor of the hypoxia-inducible factor-1 (HIF-1) pathway. Cancer Research,65(2): 605-612.

Protease-activated receptor-1 (PAR1) in human brain: localization and functional expression in astrocytes. Experimental Neurology ,188: 94-103.

Locations & Appointments

2 Office Location(s)

1

Emory Clinic, Bldg B

Emory Clinic at 1365 Clifton Rd
1365 Clifton Rd NE
Atlanta, GA 30322
  • 404-778-5770
S
2

Emory Epilepsy Center

Emory Clinic at 1365 Clifton Rd
1365 Clifton Rd NE
Atlanta, GA 30322
  • 404-778-5687
S

3 Hospital Affiliation(s)

3

Emory University Hospital Midtown

550 Peachtree St NE
Atlanta, GA 30308
H
4

Emory University Hospital

1364 Clifton Rd NE
Atlanta, GA 30322
H
5

Emory Saint Joseph's Hospital

5665 Peachtree Dunwoody Rd
Atlanta, GA 30342
H

Academic Profile

Training

MEDICAL SCHOOL

University of Minnesota Hospital, Minneapolis, MN

INTERNSHIP

University of Iowa Hospitals, Iowa City, IA

RESIDENCY

University of Iowa College of Medicine, Iowa City, IA

FELLOWSHIP

National Institute of Health, Bethesda, MD

Professional Memberships

American Association of Neurological Surgeons

American College of Surgeons

Cancer Committee, Emory University Hospital

Congress of Neurological Surgeons

Eastern Cooperative Oncology Group

Georgia Neurosurgical Society

Neuro-Oncology Working Group, WCI

PET Center Committee

Radiation Therapy Oncology Group

Research Society of Neurosurgery

Society of Surgical Oncology

Stroke Council of the American Heart Association

Honors & Awards

Young Investigator Award - AANS

Major Publications

A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting. Molecular Therapeutics,10(5):958-66.

Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors. Clinical Cancer Research,10(24): 8603-8612.

Correlation of the response of recurrent malignant gliomas treated with interferon with tumor interferon  gene content. International Journal of Oncology,25: 419-427.

Identification of a novel small molecule inhibitor of the hypoxia-inducible factor-1 (HIF-1) pathway. Cancer Research,65(2): 605-612.

Protease-activated receptor-1 (PAR1) in human brain: localization and functional expression in astrocytes. Experimental Neurology ,188: 94-103.